Target
Tyrosine-protein kinase BTK [393-659]
Ligand
BDBM287321
Substrate
n/a
Meas. Tech.
Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET)
pH
6.5±n/a
Temperature
298.15±n/a K
IC50
<100±n/a nM
Comments
extracted
Citation
 Bonafoux, DDavis, HMFrank, KEFriedman, MMHerold, JMHoemann, MZHuntley, ROsuma, ASheppard, GSomal, GKVan Camp, JVan Epps, SAVasudevan, AWallace, GAWang, LWang, LWang, ZWilson, NSXu, X Primary carboxamides as BTK inhibitors US Patent  US9567339 Publication Date 2/14/2017 
Target
Name:
Tyrosine-protein kinase BTK [393-659]
Synonyms:
AGMX1 | ATK | BPK | BTK | BTK_HUMAN | Tyrosine-protein kinase BTK
Type:
Enzyme Catalytic Domain
Mol. Mass.:
31165.48
Organism:
Human
Description:
aa 393-659
Residue:
267
Sequence:
GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES
  
Inhibitor
Name:
BDBM287321
Synonyms:
US9567339, Example D.7.26
Type:
Small organic molecule
Emp. Form.:
C26H29ClN4O4S
Mol. Mass.:
529.051
SMILES:
CCC(Cl)C(=O)Nc1cccc(c1C)-c1ccc(C(N)=O)c2[nH]c(cc12)C1=CCN(CC1)S(C)(=O)=O |t:29|
Structure:
Search PDB for entries with ligand similarity: